SomaLogic

This webinar explores the precision and correlation of leading large-scale proteomic platforms, providing essential insights for human plasma proteome profiling.

This application note showcases how this robust, highly multiplexed platform supports novel biomarker discovery in drug development and aids in developing diagnostics for a wide range of critical diseases.

This application note examines an advanced proteomics platform designed to provide high precision across thousands of proteins, enabling reliable results even in large-scale and longitudinal studies.

Recent technological progress has allowed biologists to measure an unprecedented number of these molecules throughout an organism, providing unique insights into the physiological and pathological conditions of cells and organs, including the aging

This whitepaper explores innovative proteomic tools that offer insights into protein signatures and that can serve as biomarkers for aging.

This infographic explores how a protein detection assay – which outperforms antibody-based proteomics approaches – can unlock crucial insights for developing targeted treatments and enhancing our understanding of aging and disease progression.

As proteomics platforms have advanced, the number of proteins measured and sample throughput have dramatically increased. However, have sacrifices or trade-offs been necessary to make these gains?

In this webinar, we’ll explore how integrating proteomics with systems biology sheds light on the complexities of AD pathology.

Introducing the SomaScan® 11K Assay – Pioneering proteomics. SomaLogic's high-plex, high throughput assay covers half the human proteome, empowering researchers to identify unique pathway and protein signatures. Explore the power of more.

Driving biomarker discovery is key as proteomics emerges as the next frontier in precision medicine.
In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.
This webinar will explore how reliable, non-invasive proteomic biomarkers are pivotal for personalized treatment and increasing our knowledge of biological pathways involved in disease. Our expert speaker will also present an assay platform that can measure 11,000 biologically relevant proteins in the search for biomarkers.